E-News – April 2026
Article category: News .
March 31, 2026
Our April 2026 Retina SA E‑News highlights major progress in research, advocacy and community impact, including:
- Breakthroughs in retinal research and several promising new treatment pathways.
- Major clinical trial updates for Retinitis Pigmentosa (RP), Stargardt disease, Usher Syndrome and Best’s Disease.
- Record‑breaking success of the 37th Dis‑Chem Ride for Sight, with nearly 4 000 cyclists supporting genetic testing and patient services.
- New young leaders joining our Management Committee, strengthening innovation and community representation.
- A fully redesigned Retina SA website launching soon, featuring improved accessibility and a new educational resource library.
- National and international presence, including participation in global congresses and professional events throughout 2026.
- Opportunities for members, families, supporters, and corporates to get involved through membership, donations, events, sport, and community groups.
More Articles
Article category: News .
Article title: Bionic Sight’s Optogenetic Therapy .
This exciting research enables blind patients to detect light and motion in an early trial. The therapy is designed.
LEARN MORE
Article category: News .
Article title: Dis-Chem Ride for Sight 2025 .
Thank you Dis-Chem Pharmacies for once again sponsoring the 2025 Ride for Sight.- a remarkable unbroken partnership of 17.
LEARN MORE
Article category: News .
Article title: Nanoscope Optogentic Gene Therapy .
Nanoscope's Therapeutics announced in June the results of an Optogenetic Gene Therapy trial to restore meaningful vision in 11.
LEARN MORE